Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The quick ratio (acid-test) is N/A as of Tuesday, October 6, 2026.
QUICK RATIO (ACID-TEST)
N/A
Braveheart Bio, Inc.
Market Cap
$1.40B
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.40B
Quick Ratio (Acid-Test)
11.11
TTM Avg
12.01
3Y Avg
12.01
5Y Avg
12.01
Market Cap
$1.40B
Quick Ratio (Acid-Test)
17.76
TTM Avg
8.82
3Y Avg
5.82
5Y Avg
10.42
Market Cap
$1.39B
Quick Ratio (Acid-Test)
1.20
TTM Avg
1.17
3Y Avg
1.13
5Y Avg
1.04
Market Cap
$1.42B
Quick Ratio (Acid-Test)
5.61
TTM Avg
9.29
3Y Avg
11.65
5Y Avg
16.84
Market Cap
$1.43B
Quick Ratio (Acid-Test)
1.56
TTM Avg
2.29
3Y Avg
2.59
5Y Avg
3.62
Market Cap
$1.37B
Quick Ratio (Acid-Test)
5.07
TTM Avg
3.94
3Y Avg
5.82
5Y Avg
6.31
Market Cap
$1.45B
Quick Ratio (Acid-Test)
2.94
TTM Avg
3.04
3Y Avg
2.84
5Y Avg
2.90
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | $1.40B | N/A | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | 11.11 | 12.01 | 12.01 | 12.01 |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.40B | 17.76 | 8.82 | 5.82 | 10.42 |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | 1.20 | 1.17 | 1.13 | 1.04 |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 5.61 | 9.29 | 11.65 | 16.84 |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.43B | 1.56 | 2.29 | 2.59 | 3.62 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | 5.07 | 3.94 | 5.82 | 6.31 |
| Certara, Inc. (CERT)vs › | $1.44B | 2.55 | 2.09 | 2.53 | 2.95 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 2.94 | 3.04 | 2.84 | 2.90 |
| Omeros Corporation (OMER)vs › | $1.34B | 1.94 | 2.22 | 2.95 | 3.44 |
Quick Ratio
N/A
Excludes inventory
Current Ratio
N/A
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
